You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Dow
Baxter
Moodys
McKesson

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

DISOPYRAMIDE PHOSPHATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Disopyramide Phosphate, and what generic alternatives are available?

Disopyramide Phosphate is a drug marketed by Nesher Pharms, Aurolife Pharma Llc, Interpharm, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Sun Pharm Industries, Superpharm, Teva, and Watson Labs. and is included in eighteen NDAs.

The generic ingredient in DISOPYRAMIDE PHOSPHATE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.

US ANDA Litigation and Generic Entry Outlook for Disopyramide Phosphate

A generic version of DISOPYRAMIDE PHOSPHATE was approved as disopyramide phosphate by TEVA on February 22nd, 1985.

  Start Trial

Drug patent expirations by year for DISOPYRAMIDE PHOSPHATE
Recent Clinical Trials for DISOPYRAMIDE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of AberdeenN/A
University of OxfordN/A

See all DISOPYRAMIDE PHOSPHATE clinical trials

Pharmacology for DISOPYRAMIDE PHOSPHATE
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for DISOPYRAMIDE PHOSPHATE

US Patents and Regulatory Information for DISOPYRAMIDE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE, EXTENDED RELEASE;ORAL 071200-001 Dec 15, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070240-001 Feb 2, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070187-001 Nov 18, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Interpharm DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 071190-001 Jan 15, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKinsey
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.